The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions
Colorectal CancerChemotherapeutic Toxicity
Interventions
DRUG

Clostridium butyricum capsules

Clostridium butyricum capsules , 6 capsules tid (each capsule containing ≥6.3 × 10⁶ CFU of Clostridium butyricum).

OTHER

placebo capsules

Oral administration of placebo capsules, 6 capsules tid., containing corn starch. The appearance and weight of the placebo capsules are identical to those of intervention group.

Trial Locations (1)

266071

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Linyi People's Hospital

OTHER

collaborator

Shandong Cancer Hospital and Institute

OTHER

collaborator

Yantai Yuhuangding Hospital

OTHER

collaborator

Jining First People's Hospital

OTHER

collaborator

Rizhao People's Hospital

OTHER

collaborator

Qianfoshan Hospital

OTHER

collaborator

Weifang People's Hospital

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Taian City Central Hospital

OTHER

collaborator

The Affiliated Hospital of Shandong Second Medical University

UNKNOWN

collaborator

Dongying People's Hospital

OTHER

lead

The Affiliated Hospital of Qingdao University

OTHER